22 Aug Extent of Liver Damage May Be Underestimated In Hepatitis C Patients
Posted at 13:43h
in Author Interviews, Biomarkers, Gastrointestinal Disease, Hepatitis - Liver Disease
MedicalResearch.com Interview with:
Stuart Gordon, M.D.
Director of Hepatology at Henry Ford Hospital
Detroit, Michigan
Medical Research: What is the background for this study? What are the main findings?
Dr. Gordon: The U.S. Centers for Disease Control and Prevention’s Division of Viral Hepatitis estimates 2.7 to 3.9 million people in the United States currently suffer from chronic hepatitis C. But, unfortunately, many of these patients may be unaware of the severity of their liver damage. We looked at evidence of cirrhosis among hepatitis C patients by examining four different parameters: ICD9 codes; liver biopsy reports; evidence of liver failure; and the FIB-4 test, an easily calculated biomarker. By using all four indicators of cirrhosis, we found a far higher prevalence of cirrhosis than would be indicated by any one method.

























